sec filing
TR
NASDAQ · TRDA
Entrada Therapeutics, Inc.
Healthcare · Biotechnology
$7.05
Up+$0.25 (+3.68%)
Updated Sep 15, 2026, 1:11 PM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 413.53M
- P/E ratio
- -4.34
- Dividend yield
- 0.00%
- 52-week range
- $5.02 – $16.45
- Volume
- 336.1K
- Avg. volume
- 275.51K
Price performance
TRDA price history
1M range · 20 trading sessions · Daily adjusted prices
TRDA closed at $7.05 after 20 trading sessions, down 3.69% for the selected period.
- Last close
- $7.05
- Period change
- -3.69%
- Period low
- $6.42
- Period high
- $7.78
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $6.80 | $7.07 | $6.72 | $7.05 | 336.1K |
| Sep 11, 2026 | $6.49 | $6.81 | $6.29 | $6.80 | 291.81K |
| Sep 10, 2026 | $7.00 | $7.175 | $6.38 | $6.42 | 448.06K |
| Sep 9, 2026 | $7.47 | $7.55 | $7.02 | $7.11 | 382.04K |
| Sep 8, 2026 | $7.02 | $7.70 | $6.945 | $7.52 | 514.21K |
| Sep 4, 2026 | $7.11 | $7.17 | $7.00 | $7.13 | 341.73K |
| Sep 3, 2026 | $7.31 | $7.4228 | $7.04 | $7.17 | 395.56K |
| Sep 2, 2026 | $7.07 | $7.34 | $6.96 | $7.30 | 306.54K |
| Sep 1, 2026 | $6.95 | $7.1785 | $6.80 | $7.07 | 205.48K |
| Aug 31, 2026 | $6.84 | $7.17 | $6.76 | $7.05 | 450.41K |
| Aug 28, 2026 | $7.18 | $7.24 | $6.935 | $7.00 | 111.6K |
| Aug 27, 2026 | $7.02 | $7.37 | $6.80 | $7.27 | 248.6K |
| Aug 26, 2026 | $7.55 | $7.64 | $6.9538 | $7.00 | 229.32K |
| Aug 25, 2026 | $7.39 | $7.67 | $7.39 | $7.62 | 269.98K |
| Aug 24, 2026 | $7.58 | $7.58 | $7.12 | $7.33 | 184.25K |
| Aug 21, 2026 | $7.64 | $7.735 | $7.44 | $7.57 | 141.02K |
| Aug 20, 2026 | $7.76 | $7.765 | $7.30 | $7.60 | 250.04K |
| Aug 19, 2026 | $7.49 | $7.79 | $7.395 | $7.78 | 241.84K |
| Aug 18, 2026 | $7.21 | $7.43 | $7.16 | $7.27 | 129.76K |
| Aug 17, 2026 | $7.33 | $7.56 | $7.25 | $7.32 | 193.11K |
Latest TRDA news
The latest Smart Investors Daily articles mentioning TRDA.
Stock researchResearch & News · Analysis
Loading stock research…

